Skip to Content


In the US, Cyramza (ramucirumab systemic) is a member of the drug class VEGF/VEGFR inhibitors and is used to treat Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer and Stomach Cancer.

US matches:

UK matches:

Ingredient matches for Cyramza


Ramucirumab is reported as an ingredient of Cyramza in the following countries:

  • Croatia (Hrvatska)
  • France
  • Germany
  • Ireland
  • Poland
  • Slovakia
  • Slovenia
  • Switzerland
  • United Kingdom
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.